Regulatory Science in Action
Developing new tools, standards, and approaches to assess drug safety, efficacy, quality, and performance
1
Sub-Topic Paragraphs
RECENT ADVANCES IN THE SCIENCE OF DRUG DEVELOPMENT AND EVALUATION

Spotlight on CDER Science:
Respiratory Effects of Approved Opioid Products When Co-administered with Commonly Prescribed Drugs

Impact story:
Prescription drug promotion in online character space limited (CSL) communication

CDER Conversations:
Biosimilar User Fee Amendments Latest Implementation: BsUFA III

What's New in Regulatory Science Winter 2022:
A newsletter featuring new developments and opportunities for stakeholders